Diflorasone diacetate 0.5 MG/ML Topical Cream — RxCUI 966577
RxNorm drug concept · Semantic clinical drug
RxCUI 966577
Semantic clinical drug · SCD
● Current RxNorm concept 1 FDA product
3 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI966577
Official nameDiflorasone diacetate 0.5 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asdiflorasone diacetate 0.05 % Topical Cream
FDA products mapped1
Package NDCs mapped3
Reported Medicaid activity (SDUD)7,668 prescriptions · 6 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Diflorasone Topical: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It relieves inflammation and itching from skin conditions that respond to steroids. It is a high potency steroid, so it is stronger than many over-the-counter creams.
- For the ointment, spread a thin film over the affected skin one to three times a day, depending on how severe your condition is. Follow your prescriber's directions and the label.
- Only if your prescriber tells you to. Airtight dressings can be used for psoriasis or stubborn conditions, but they increase absorption and side effects. If an infection develops,...
- Burning, itching, irritation or dryness are the most common. Less often you may see acne-like bumps, lighter skin or inflamed hair follicles. Call if you notice skin thinning, stre...
🕸️ Concept Web — How Diflorasone diacetate 0.5 MG/ML Topical Cream Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Diflorasone diacetate 0.5 MG/ML Topical Cream
RxCUI 966577 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 2
The active substance itself — no strength, form, or brand attached yet.
-
Diflorasone
91311IN -
Diflorasone diacetate
23033PIN
-
Diflorasone
-
Brand names 2
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Apexicon
404858BN -
Psorcon
219507BN
-
Apexicon
-
Dose forms 12
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Diflorasone Topical Cream
378610SCDF -
Diflorasone diacetate Topical Cream
2645647SCDFP -
Diflorasone Topical Product
1151507SCDG -
Diflorasone diacetate Topical Product
2659280SCDGP -
Diflorasone Topical Cream [Apexicon]
966819SBDF -
Diflorasone Topical Cream [Psorcon]
362170SBDF -
Diflorasone diacetate Topical Cream [Apexicon]
2655872SBDFP -
Diflorasone diacetate Topical Cream [Psorcon]
2656629SBDFP - +4 more in this family
-
Diflorasone Topical Cream
-
Clinical & branded drugs 5
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Diflorasone diacetate 0.5 MG/ML
966576SCDC -
Diflorasone diacetate 0.5 MG/ML Topical Cream [Apexicon]
966820SBD -
Diflorasone diacetate 0.5 MG/ML Topical Cream [Psorcon]
966589SBD -
Diflorasone diacetate 0.5 MG/ML [Apexicon]
966818SBDC -
Diflorasone diacetate 0.5 MG/ML [Psorcon]
966588SBDC
-
Diflorasone diacetate 0.5 MG/ML
Showing up to 8 concepts per family — 17 of 21 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Diflorasone diacetate 0.5 MG/ML
SCDC · 966576 -
Diflorasone Topical Cream
SCDF · 378610 -
Diflorasone diacetate Topical Cream
SCDFP · 2645647 -
Diflorasone Topical Product
SCDG · 1151507 -
Diflorasone diacetate Topical Product
SCDGP · 2659280
Brand-Name Concepts
-
Diflorasone diacetate 0.5 MG/ML Topical Cream [Apexicon]
SBD · 966820 -
Diflorasone diacetate 0.5 MG/ML Topical Cream [Psorcon]
SBD · 966589 -
Diflorasone diacetate 0.5 MG/ML [Apexicon]
SBDC · 966818 -
Diflorasone diacetate 0.5 MG/ML [Psorcon]
SBDC · 966588 -
Diflorasone Topical Cream [Apexicon]
SBDF · 966819 -
Diflorasone Topical Cream [Psorcon]
SBDF · 362170 -
Diflorasone diacetate Topical Cream [Apexicon]
SBDFP · 2655872 -
Diflorasone diacetate Topical Cream [Psorcon]
SBDFP · 2656629 -
Apexicon Topical Product
SBDG · 1168556 -
Psorcon Topical Product
SBDG · 1183544
📦 FDA Products & Package NDCs
1 product · 3 package NDCs
3 package NDCs map to RxCUI 966577 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 51672-1296-01 | 1 TUBE in 1 CARTON (51672-1296-1) / 15 g in 1 TUBE | Diflorasone Diacetate | Sun Pharmaceutical Industries, Inc. | 2000-04-24 |
| 51672-1296-02 | 1 TUBE in 1 CARTON (51672-1296-2) / 30 g in 1 TUBE | Diflorasone Diacetate | Sun Pharmaceutical Industries, Inc. | 2000-04-24 |
| 51672-1296-03 | 1 TUBE in 1 CARTON (51672-1296-3) / 60 g in 1 TUBE | Diflorasone Diacetate | Sun Pharmaceutical Industries, Inc. | 2000-04-24 |
Observed labelers:
Sun Pharmaceutical Industries, Inc. (3)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
💲 Pricing (NADAC)
NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.
Per gm · median
$5.3020
Range $4.3716–$6.2323
· middle 50% $4.8368–$5.7671
· 2 NDCs
Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.